Novartis Clozapine Anti-Generic Study Has Not Persuaded State Formularies
Executive Summary
Novartis' presentations of recent study data questioning the interchangeability of its antipsychotic Clozaril and Zenith's generic clozapine have not persuaded any states to restrict generic substitution of the drugs.